David H Chae1, Cristina M Drenkard1, Tené T Lewis1, S Sam Lim1. 1. David H. Chae is with the Department of Epidemiology and Biostatistics, School of Public Health, University of Maryland, College Park. Cristina M. Drenkard and S. Sam Lim are with the Division of Rheumatology, School of Medicine, and Tené T. Lewis is with the Department of Epidemiology, Rollins School of Public Health, Emory University, Atlanta, GA.
Abstract
OBJECTIVES: We examined associations between unfair treatment, attributions of unfair treatment to racial discrimination, and cumulative disease damage among African American women with systemic lupus erythematosus (SLE). METHODS: We used multivariable regression models to examine SLE damage among 578 African American women in metropolitan Atlanta, Georgia, recruited to the Georgians Organized Against Lupus cohort. RESULTS: When we controlled for demographic, socioeconomic, and health-related covariates, reporting any unfair treatment was associated with greater SLE damage compared with reporting no unfair treatment (b = 0.55; 95% confidence interval = 0.14, 0.97). In general, unfair treatment attributed to nonracial factors was more strongly associated with SLE damage than was unfair treatment attributed to racial discrimination, although the difference was not statistically significant. CONCLUSIONS: Unfair treatment may contribute to worse disease outcomes among African American women with SLE. Unfair treatment attributed to nonracial causes may have a more pronounced negative effect on SLE damage. Future research may further examine possible differences in the effect of unfair treatment by attribution.
OBJECTIVES: We examined associations between unfair treatment, attributions of unfair treatment to racial discrimination, and cumulative disease damage among African American women with systemic lupus erythematosus (SLE). METHODS: We used multivariable regression models to examine SLE damage among 578 African American women in metropolitan Atlanta, Georgia, recruited to the Georgians Organized Against Lupus cohort. RESULTS: When we controlled for demographic, socioeconomic, and health-related covariates, reporting any unfair treatment was associated with greater SLE damage compared with reporting no unfair treatment (b = 0.55; 95% confidence interval = 0.14, 0.97). In general, unfair treatment attributed to nonracial factors was more strongly associated with SLE damage than was unfair treatment attributed to racial discrimination, although the difference was not statistically significant. CONCLUSIONS: Unfair treatment may contribute to worse disease outcomes among African American women with SLE. Unfair treatment attributed to nonracial causes may have a more pronounced negative effect on SLE damage. Future research may further examine possible differences in the effect of unfair treatment by attribution.
Authors: DeMarc A Hickson; Tené T Lewis; Jiankang Liu; David L Mount; Sinead N Younge; William C Jenkins; Daniel F Sarpong; David R Williams Journal: Ann Behav Med Date: 2012-02
Authors: Tené T Lewis; Susan A Everson-Rose; Lynda H Powell; Karen A Matthews; Charlotte Brown; Kelly Karavolos; Kim Sutton-Tyrrell; Elizabeth Jacobs; Deidre Wesley Journal: Psychosom Med Date: 2006 May-Jun Impact factor: 4.312
Authors: S Sam Lim; A Rana Bayakly; Charles G Helmick; Caroline Gordon; Kirk A Easley; Cristina Drenkard Journal: Arthritis Rheumatol Date: 2014-02 Impact factor: 10.995
Authors: Sarah L Szanton; Joseph M Rifkind; Joy G Mohanty; Edgar R Miller; Roland J Thorpe; Eneka Nagababu; Elissa S Epel; Alan B Zonderman; Michele K Evans Journal: Int J Behav Med Date: 2012-12
Authors: C Drenkard; J Yazdany; L Trupin; P P Katz; C Dunlop-Thomas; G Bao; S S Lim Journal: Arthritis Care Res (Hoboken) Date: 2014-06 Impact factor: 4.794
Authors: Edith M Williams; J Madison Hyer; Ramakrishnan Viswanathan; Trevor D Faith; Delia Voronca; Mulugeta Gebregziabher; Jim C Oates; Leonard Egede Journal: Arthritis Care Res (Hoboken) Date: 2018-04-18 Impact factor: 4.794
Authors: C R Phillip; K Mancera-Cuevas; C Leatherwood; J S Chmiel; D L Erickson; E Freeman; G Granville; M Dollear; K Walker; R McNeil; C Correia; P Canessa; R Ramsey-Goldman; C H Feldman Journal: Lupus Date: 2019-10-08 Impact factor: 2.911
Authors: Connor D Martz; Amani M Allen; Thomas E Fuller-Rowell; Erica C Spears; S Sam Lim; Cristina Drenkard; Kara Chung; Evelyn A Hunter; David H Chae Journal: J Racial Ethn Health Disparities Date: 2019-06-18
Authors: David H Chae; Connor D Martz; Thomas E Fuller-Rowell; Erica C Spears; Tianqi Tenchi Gao Smith; Evelyn A Hunter; Cristina Drenkard; S Sam Lim Journal: Am J Epidemiol Date: 2019-08-01 Impact factor: 4.897
Authors: Miriam E Van Dyke; Nicole Kau'i Baumhofer; Natalie Slopen; Mahasin S Mujahid; Cheryl R Clark; David R Williams; Tené T Lewis Journal: Psychosom Med Date: 2020-04 Impact factor: 3.864
Authors: Edith M Williams; Leonard Egede; Jim C Oates; Clara L Dismuke; Viswanathan Ramakrishnan; Trevor D Faith; Hetlena Johnson; Jillian Rose Journal: Trials Date: 2019-08-23 Impact factor: 2.279
Authors: Erica C Spears; Amani M Allen; Kara W Chung; Connor D Martz; Evelyn A Hunter; Thomas E Fuller-Rowell; S Sam Lim; Christina Drenkard; David H Chae Journal: J Behav Med Date: 2021-06-22
Authors: Wendy Rodgers; Edith M Williams; Brittany L Smalls; Tyler Singleton; Ashley Tennessee; Diane Kamen; Gary Gilkeson Journal: Int J Environ Res Public Health Date: 2020-03-28 Impact factor: 3.390